These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2006-004886-33||A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL OF THE SAFETY AND IMMUNOMODULATORY THERAPY FOR THE MANAGEMENT OF SEPSIS||not-yet-due|
|Completed, but no date||2007-004289-42||90Y ibritumomab tiuxetan (Zevalin®) in patients with extra-nodal marginal zone B-cell lymphoma of Mucosa associated lymphoid tissue (MALT Lymphoma)||bad-data|
|Completed, but no date||2008-004807-67||AN OPEN-LABEL, NON-RANDOMIZED PHASE IV CLINICAL TRIAL OF THE EFFICACY OF INTRAVENOUSLY ADMINISTERED 1000MG PARACETAMOL AS ANTIPYRETIC AND ANALGESIC MEDICATION||bad-data|
|Not reported||2010-021413-23||Optimizing Dosing of Colistin for Infections Resistant to all Other Antibiotics||2014-08-01||due-trials|
|Not reported||2011-005145-12||A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED CLINICAL TRIAL OF THE SAFETY AND EFFICACY OF ANAKINRA IN PATIENTS WITH HIDRADENITIS SUPPURATIVA (PROTOCOL: HIDRA03)||2014-08-01||due-trials|
|Not reported||2011-005333-39||The effects of acute sildenafil administration on inflammatory markers in patients with vasculogenic erectile dysfunction.||2014-01-17||due-trials|
|Not reported||2012-000933-37||Phase II trial of ofatumumab combined with ESHAP as salvage therapy before autologous stem cell transplantation, for patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL) previous...||2016-01-11||due-trials|
|Ongoing||2012-004819-31||Multicenter open-label RCT to compare colistin alone vs. colistin plus meropenem||not-yet-due|
|Ongoing||2012-004998-53||A phase II study of the efficacy of the combination of ofatumumab with fludarabine and cyclophosphamide in patients with relapsed or refractory Waldenström’s Macroglobulinemia.||not-yet-due|
|Ongoing||2015-005630-21||A Prospective, Multicentre, Randomized, Open Label, Blinded Endpoint, Phase 3 Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr with Acetylsalicylic Acid versus CLopidogrel with Acety...||not-yet-due|
|Ongoing||2016-002586-64||A randomized, pharmacodynamic study of cangrelor administration in STEMI patients loaded with ticagrelor||not-yet-due|
|Ongoing||2016-004959-80||A randomized, pharmacodynamic comparison of ticagrelor 60mg bid vs prasugrel 5mg in patients with prior myocardial infarction||not-yet-due|